Shanghai Pharmaceuticals Holding Co., Ltd

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 1099.HK has a market cap of 57.70B. Regarding current trading prices, 2607.HK is priced at $11.12, while 1099.HK trades at $18.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 1099.HK's P/E ratio is 7.57. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 1099.HK's ROE of +0.09%. Regarding short-term risk, 2607.HK is more volatile compared to 1099.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 2192.HK has a market cap of 8.69B. Regarding current trading prices, 2607.HK is priced at $11.12, while 2192.HK trades at $11.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 2192.HK's P/E ratio is 25.78. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 2192.HK's ROE of +0.07%. Regarding short-term risk, 2607.HK is less volatile compared to 2192.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 1931.HK has a market cap of 2.68B. Regarding current trading prices, 2607.HK is priced at $11.12, while 1931.HK trades at $1.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 1931.HK's P/E ratio is 8.68. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 1931.HK's ROE of +0.07%. Regarding short-term risk, 2607.HK is less volatile compared to 1931.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 2289.HK has a market cap of 837.00M. Regarding current trading prices, 2607.HK is priced at $11.12, while 2289.HK trades at $7.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 2289.HK's P/E ratio is 14.62. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 2289.HK's ROE of +0.09%. Regarding short-term risk, 2607.HK is more volatile compared to 2289.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 9955.HK has a market cap of 682.04M. Regarding current trading prices, 2607.HK is priced at $11.12, while 9955.HK trades at $1.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 9955.HK's P/E ratio is -1.10. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 9955.HK's ROE of -0.12%. Regarding short-term risk, 2607.HK is less volatile compared to 9955.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 0718.HK has a market cap of 136.50M. Regarding current trading prices, 2607.HK is priced at $11.12, while 0718.HK trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 0718.HK's P/E ratio is -0.19. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 0718.HK's ROE of +0.60%. Regarding short-term risk, 2607.HK is less volatile compared to 0718.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 8372.HK has a market cap of 95.20M. Regarding current trading prices, 2607.HK is priced at $11.12, while 8372.HK trades at $0.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 8372.HK's P/E ratio is 11.90. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 8372.HK's ROE of +0.08%. Regarding short-term risk, 2607.HK is less volatile compared to 8372.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 0673.HK has a market cap of 68.83M. Regarding current trading prices, 2607.HK is priced at $11.12, while 0673.HK trades at $0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 0673.HK's P/E ratio is -1.56. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 0673.HK's ROE of -0.89%. Regarding short-term risk, 2607.HK is less volatile compared to 0673.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.

2607.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 2607.HK stands at 65.23B. In comparison, 0401.HK has a market cap of 38.10M. Regarding current trading prices, 2607.HK is priced at $11.12, while 0401.HK trades at $0.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

2607.HK currently has a P/E ratio of 8.76, whereas 0401.HK's P/E ratio is -1.13. In terms of profitability, 2607.HK's ROE is +0.06%, compared to 0401.HK's ROE of -0.47%. Regarding short-term risk, 2607.HK is less volatile compared to 0401.HK. This indicates potentially lower risk in terms of short-term price fluctuations for 2607.HK.